PerkinElmer Inc (NYSE:PKI)
| 128.27 Delayed Data As of Mar 28 |  +0.27 / +0.21%Today’s Change | 113.46 Today|||52-Week Range 181.66 | -8.52% Year-to-Date |
Latest PKI News | Press Releases
| Here's Why You Should Retain PerkinElmer (PKI) Stock Now Mar 24 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 128.00 |
| Today’s open | 127.69 |
| Day’s range | 127.30 - 128.65 |
| Volume | 669,960 |
| Average volume (3 months) | 821,024 |
| Market cap | $16.1B |
Data as of 3:59pm ET, 03/28/2023
Growth & Valuation
| Earnings growth (last year) | -44.44% |
| Earnings growth (this year) | -36.01% |
| Earnings growth (next 5 years) | -3.39% |
| Revenue growth (last year) | -34.64% |
| P/E ratio | 31.6 |
| Price/Sales | 5.35 |
| Price/Book | 2.18 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| WATWaters Corp | -3.31 | -1.09% |
| BIOBio Rad Laboratories... | +0.26 | +0.06% |
| BRKRBruker Corp | -0.28 | -0.37% |
| QGENQiagen NV | -0.67 | -1.44% |
Data as of 4:00pm ET, 03/28/2023
Financials
| Next reporting date | May 2, 2023 |
| EPS forecast (this quarter) | $0.99 |
| Annual revenue (last year) | $3.3B |
| Annual profit (last year) | $569.2M |
| Net profit margin | 15.48% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
